He’s someone Trump really looks up to and wants to make happy,” a source said of LVMH CEO Bernard Arnault, the wealthiest man in France.
Jean Arnault, director of Louis Vuitton’s watch division, has to contend with a tough luxury market and stubborn young consumers.
LVMH, which is controlled by the family of multibillionaire Bernard Arnault, was a major sponsor of the Summer Games in Paris.
While millions know at this point that Melania Trump adores Dior, it seems that Ivanka has a soft spot for the European house, too. The former West Wing adviser wore a Dior dark forest green skirt suit with a thin black belt and a coordinating beret-style hat to the Inauguration ceremony at the U.
The medals were designed by a jewelry maker owned by the French luxury conglomerate, which has declined to comment on their deterioration.
Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.
At LVMH Watch Week, Daniel Roth debuted its latest timepiece, the Extra Plat Souscription. Inspired by its Tourbillon Souscription watch, Daniel Roth has reinterpreted the design in a new laidback way – but as a limited edition novelty, you might not be able to get one.
The rest of the top ten largest companies in Europe by market cap include ASML ( ASML ), SAP SE ( SAP ), Hermès International ( OTCPK:HESAY ), Roche Holding AG ( OTCQX:RHHBY ), Accenture plc ( ACN ), Nestlé S.A ( OTCPK:NSRGY ), AstraZeneca PLC ( AZN ), and Novartis AG ( NVS ).
Billionaires like Elon Musk and Jeff Bezos owe their success to prestigious universities, shaping their paths through innovation and education.
The trial tested amycretin in its injectable form, but Novo Nordisk is also separately developing the drug in pill form. Investors cheered an early trial of the pill early last year that showed weight loss of around 13% after 12 weeks, better than the 6% weight loss patients experienced after 12 weeks in a Wegovy trial.
Geographically, the consumer goods Goliath is trending back towards growth in Greater China. Organic sales in the region were down just -3% in Q2 2025 on the prior year quarter. Whereas in Q1 2025, they were down -15% on the prior year quarter. The company described this as an encouraging momentum towards recovery.